» Articles » PMID: 29651418

Role of the Sympathetic Nervous System and Its Modulation in Renal Hypertension

Overview
Specialty General Medicine
Date 2018 Apr 14
PMID 29651418
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

The kidneys are densely innervated with renal efferent and afferent nerves to communicate with the central nervous system. Innervation of major structural components of the kidneys, such as blood vessels, tubules, the pelvis, and glomeruli, forms a bidirectional neural network to relay sensory and sympathetic signals to and from the brain. Renal efferent nerves regulate renal blood flow, glomerular filtration rate, tubular reabsorption of sodium and water, as well as release of renin and prostaglandins, all of which contribute to cardiovascular and renal regulation. Renal afferent nerves complete the feedback loop central autonomic nuclei where the signals are integrated and modulate central sympathetic outflow; thus both types of nerves form integral parts of the self-regulated renorenal reflex loop. Renal sympathetic nerve activity (RSNA) is commonly increased in pathophysiological conditions such as hypertension and chronic- and end-stage renal disease. Increased RSNA raises blood pressure and can contribute to the deterioration of renal function. Attempts have been made to eliminate or interfere with this important link between the brain and the kidneys as a neuromodulatory treatment for these conditions. Catheter-based renal sympathetic denervation has been successfully applied in patients with resistant hypertension and was associated with significant falls in blood pressure and renal protection in most studies performed. The focus of this review is the neural contribution to the control of renal and cardiovascular hemodynamics and renal function in the setting of hypertension and chronic kidney disease, as well as the specific roles of renal efferent and afferent nerves in this scenario and their utility as a therapeutic target.

Citing Articles

The road to renal denervation for hypertension and beyond (HF): two decades of failed, succeeded, and to be determined.

Jiang H, Kittipibul V, Mahfoud F, Bohm M, Sobotka P, Esler M Heart Fail Rev. 2024; 30(2):293-314.

PMID: 39509056 DOI: 10.1007/s10741-024-10463-1.


Comprehensive mapping of sensory and sympathetic innervation of the developing kidney.

NGuetta P, McLarnon S, Tassou A, Geron M, Shirvan S, Hill R Cell Rep. 2024; 43(10):114860.

PMID: 39412983 PMC: 11616766. DOI: 10.1016/j.celrep.2024.114860.


Palmitoylation regulates norepinephrine transporter uptake, surface localization, and total expression with pathogenic implications in postural orthostatic tachycardia syndrome.

Brown C, Shetty M, Foster J J Neurochem. 2024; 169(2):e16241.

PMID: 39395208 PMC: 11808474. DOI: 10.1111/jnc.16241.


A Review of the Risk Factors and Management of Refractory Hypertension: The Role of Carotid Sinus Stimulation and Renal Nerve Denervation.

Nwosu I, Oladiran O, Rivera M, Oladiran O, Nwosu A, Dim C J Community Hosp Intern Med Perspect. 2024; 14(4):18-24.

PMID: 39391106 PMC: 11464058. DOI: 10.55729/2000-9666.1364.


Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review.

Zheng H, Sechi L, Navarese E, Casu G, Vidili G Cardiovasc Diabetol. 2024; 23(1):346.

PMID: 39342178 PMC: 11439309. DOI: 10.1186/s12933-024-02434-5.


References
1.
Mayyas F, Sturey T, Van Wagoner D . Baroreflex stimulation versus renal denervation for treatment of hypertension: what constitutes a logical comparison of these interventions on atrial electrophysiology?. J Cardiovasc Electrophysiol. 2013; 24(9):1034-6. PMC: 3770820. DOI: 10.1111/jce.12185. View

2.
Schlaich M, Sata Y, Esler M . CrossTalk opposing view: Which technique for controlling resistant hypertension? Renal nerve ablation. J Physiol. 2014; 592(18):3937-40. PMC: 4198000. DOI: 10.1113/jphysiol.2014.270710. View

3.
Jordan J . CrossTalk opposing view: Which technique for controlling resistant hypertension? Carotid sinus stimulation. J Physiol. 2014; 592(18):3933-5. PMC: 4197999. DOI: 10.1113/jphysiol.2013.268078. View

4.
Esler M, Lambert G, Brunner-La Rocca H, Vaddadi G, Kaye D . Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiol Scand. 2003; 177(3):275-84. DOI: 10.1046/j.1365-201X.2003.01089.x. View

5.
Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G . Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension. 1998; 31(1):64-7. DOI: 10.1161/01.hyp.31.1.64. View